Form D · Biotechnology
CardioCell, LLC
San Diego, CA · CIK 0001633180
Offering snapshot reported May 26, 2015 · SEC filing
- Reported sold
- $1.06M Offering amount: $1.06M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 2, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 26, 2015 | Initial | $1,060,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-240488
Offering of $1,060,000 of Series A Preferred Units.
Source: Form D, filed May 26, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Stephen Epstein | Director |
| Roger J. Howe | Director |
| Richard Jaffe | Director |
| Sergey Leshkov | Director |
| Sergey Sikora | Director, Executive |
| Thomas Silberg | Director |
| Leo Spiegel | Director |
| Robert S. Sullivan | Director |
| Nikolai Tankovich | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
5375 Mira Sorrento Place Suite 100
San Diego, CA, 92121
San Diego, CA, 92121